PPARα transgenic mice exhibited arrays of diabetic cardiomyopathy phenotypes including cardiac hypertrophy, systolic dysfunction, and reduced glucose uptake and oxidation [27, 28]. This evidence concerns the gene PPARA and cardiac hypertrophy.